Outlook Therapeutics Ownership | Who Owns Outlook Therapeutics?


OverviewForecastRevenueFinancialsChart

Outlook Therapeutics Ownership Summary


Outlook Therapeutics is owned by 5.34% institutional investors, 20.85% insiders, and 73.81% retail investors. Vanguard group is the largest institutional shareholder, holding 4.21% of OTLK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.38% of its assets in Outlook Therapeutics shares.

OTLK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOutlook Therapeutics5.34%20.85%73.81%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.47M4.21%$2.31M
Schonfeld strategic advisors715.17K1.94%$758.08K
Blackrock funding, inc. /de404.54K1.16%$639.18K
Geode capital management316.46K0.91%$500.12K
Ubs group209.54K0.60%$331.07K
Commonwealth equity services112.50K0.32%$177.75K
Simplex trading105.80K0.30%$167.16K
Jane street group104.66K0.30%$165.37K
Scotia capital73.99K0.21%$116.90K
State street75.30K0.20%$79.82K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Christensen, king & associates investment services28.33K0.02%$44.76K
Flower city capital20.00K0.02%$31.60K
Northwestern mutual wealth management68.44K0.01%$17.59M
Lvw advisors48.23K0.01%$76.21K
Two sigma securities35.66K0.01%$37.80K
Schonfeld strategic advisors715.17K0.00%$758.08K
Point72 asia (singapore) pte.5.82K0.00%$6.16K
Xtx topco11.01K0.00%$11.67K
Scotia capital73.99K0.00%$116.90K
Harbour investments10.15K0.00%$16.04K

Top Buyers

HolderShares% AssetsChange
Ubs group209.54K0.00%161.43K
Vanguard group1.47M-122.54K
Jane street group104.66K-78.84K
Northwestern mutual wealth management68.44K0.01%66.31K
Two sigma securities35.66K0.01%35.66K

Top Sellers

HolderShares% AssetsChange
Sphera funds management---857.14K
Schonfeld strategic advisors715.17K0.00%-649.64K
Rosalind advisors---450.00K
Tang capital management---400.00K
Fmr106.00--170.40K

New Positions

HolderShares% AssetsChangeValue
Two sigma securities35.66K0.01%35.66K$37.80K
Jones financial companies lllp2.50K-2.50K$2.42K
International assets investment management1.00K0.00%1.00K$1.58K
Fortitude family office424.000.00%424.00$670.00
Ifp advisors50.00-50.00$79.00

Sold Out

HolderChange
True wealth design-20.00
Corecap advisors-62.00
Tradewinds capital management-100.00
Sterling capital management-116.00
Wealthspire advisors-300.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202513-77.59%1,856,635-54.47%54.38%7-69.57%--100.00%
Sep 30, 202516-73.77%1,609,381-69.77%41.46%8-75.00%4-75.00%
Jun 30, 2025641.59%5,935,574-16.22%193.65%33-13.16%1838.46%
Mar 31, 2025633.28%7,084,42564.93%227.30%388.57%138.33%
Dec 31, 202461-12.86%4,295,401-48.73%170.87%35-12.50%1220.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF442.51K1.38%-
Vanguard Total Stock Mkt Idx Inv942.80K1.14%-
CREF Stock R1100.34K0.42%65.13K
Abante Quant Value FI341.32K0.41%-47.13K
Fidelity Small Cap Index169.90K0.40%-6.23K
Vanguard Institutional Extnd Mkt Idx Tr313.93K0.38%-
Federated Hermes MDT Small Cap Growth IS88.30K0.37%88.30K
Federated Hermes MDT SCG Institutional88.30K0.37%88.30K
iShares Russell 2000 Growth ETF100.13K0.23%-
State St Russell Sm/Mid Cp® Indx NL Cl C66.90K0.21%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 26, 2024KENYON LAWRENCE A Chief Financial OfficerBuy$28.45K
Apr 15, 2024Syntone Ventures LLC-Buy$8.25M
Apr 15, 2024Syntone Ventures LLC-Buy$5.00M
Mar 28, 2024Haddadin Yezan Munther-Buy$22.24K
Mar 07, 2024Evanson Jeff CHIEF COMMERCIAL OFFICERBuy$26.24K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--

OTLK Ownership FAQ


Who Owns Outlook Therapeutics?

Outlook Therapeutics shareholders are primarily institutional investors at 5.34%, followed by 20.85% insiders and 73.81% retail investors. The average institutional ownership in Outlook Therapeutics's industry, Biotech Stocks , is 381.47%, which Outlook Therapeutics falls below.

Who owns the most shares of Outlook Therapeutics?

Outlook Therapeutics’s largest shareholders are Vanguard group (1.47M shares, 4.21%), Schonfeld strategic advisors (715.17K shares, 1.94%), and Blackrock funding, inc. /de (404.54K shares, 1.16%). Together, they hold 7.31% of Outlook Therapeutics’s total shares outstanding.

Does Blackrock own Outlook Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Outlook Therapeutics.

Who is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested?

Christensen, king & associates investment services is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 28.33K Outlook Therapeutics shares, valued at 44.76K$.

Who is the top mutual fund holder of Outlook Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Outlook Therapeutics shares, with 1.38% of its total shares outstanding invested in 442.51K Outlook Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools